Rechercher un événement
Spectacles, événements grand-public ou professionnels,
au Palais des Expositions ou au Palais des Congrès,
choisissez votre Catégorie
The 6th World Symposium on Pulmonary Hypertension will take place in Nice from February 27 to March 1, 2018. Traditionally the PH World Symposia series, started in Geneva in 1973 and held every 5 years after the Evian edition in 1998 (Venice 2003, Dana Point 2008, Nice 2013), has marked the progresses in pulmonary hypertension science and has anticipated future developments. The published supplement including the symposia proceedings constitutes a collection of articles among the most cited in this scientific area.
Each new edition of the WSPH series has increased the attendance compared with the previous one, testifying the growing interest of the stakeholders of this area. More than 1200 international physicians attended the 5th WSPH – Nice 2013.
The objectives of the 6th WSPH will be as follows:
– Review of the major advances in pulmonary vascular science in the past 5 years
– Analyze the available evidence in different basic and clinical areas by expert task forces
– Evaluation of the gaps of evidence in different areas and proposals for future collaborative research programs
– Elaboration of documents by the task forces, summarizing the results of pre-symposium meetings (previous 18-24 months)
– Discussion of the task forces documents at the symposium sessions with worldwide experts and with other stakeholders
– Final drafting of peer reviewed papers to be included in a supplement (prestigious medical journal) to facilitate the implementation of the 6th WSPH conclusions.
Our purpose is to foster with the Symposium constructive scientific interactions and collaborations in the very unique scenario of the bay of Nice.
ISHLT is a leading organization providing education for medical professionals involved in heart and lung transplantation. Because of the rapid advances in medicine in general and transplantation medicine specifically, transplant professionals are in need of regular opportunities to update and maintain their knowledge of advances and changes in transplant medicine. These meetings are designed to address this need.
To enable participants to learn about current practices, emerging technologies, and medical advances related to heart and lung transplantation and end-stage heart and lung disease; and to provide a forum for participants to engage in discussion, debate, and examination regarding the efficacy and applicability of these current practices, emerging technologies, and medical advances.
The audience for this program includes physicians, surgeons, scientists, pharmacists, nurses, transplant coordinators and other allied health and social science professionals engaged in the management and treatment of heart and lung transplant recipients, the management and treatment of patients with end-stage heart or lung disease, basic science or clinical research related to these fields, or other specialties which cause them to become involved in the treatment of transplant recipients or patients with endstage heart or lung disease.
With an emphasis on the ‘HOW’ to make Digital Transformation a reality. TM Forum Live! 2018 provides impartial, actionable advice and the practical next steps you’ll need to navigate and manage this new environment and the complicated digital ecosystems which now exist.
TIMM-9 is the 9th in the series of TIMM mycological international meetings organized jointly by the European Confederation of Medical Mycology (ECMM) and the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (IDG-EORTC). TIMM has become an important and essential meeting in the field of fungal infections, a forum in which researchers from all over the world present the most important advances and research findings in mycology from basic science to clinical and laboratory research.
Congrès bisannuel organisé conjointement avec ECCM (European Confederation of Medical Mycology).
Trends in Medical Mycology is the bi-annual joined meeting of the Infectious Disease Group of the European Organisation for Research and Treatment of Cancer (EORTC).